NDC 68788-8171 – Terazosin
Terazosin Hydrochloride 2 mg/1 · Capsule · Oral
Product NDC68788-8171
Product details
- Brand name
- Terazosin
- Generic name
- Terazosin
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA075614
- Marketed since
- April 25, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Terazosin Hydrochloride 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68788-8171-3 | 30 CAPSULE in 1 BOTTLE (68788-8171-3) | Apr 25, 2022 |
Other Terazosin products
- 50090-2623 Terazosin Hydrochloride 2 mg/1 · Capsule · A-S Medication Solutions
- 50090-7851 Terazosin Hydrochloride 1 mg/1 · Capsule · A-S Medication Solutions
- 50090-2371 Terazosin Hydrochloride 10 mg/1 · Capsule · A-S Medication Solutions
- 50090-1559 Terazosin Hydrochloride 5 mg/1 · Capsule · A-S Medication Solutions
- 50090-0657 Terazosin Hydrochloride 1 mg/1 · Capsule · A-S Medication Solutions
- 27241-288 Terazosin Hydrochloride 1 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-289 Terazosin Hydrochloride 2 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-290 Terazosin Hydrochloride 5 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-291 Terazosin Hydrochloride 10 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 53401-022 Terazosin Hydrochloride 1 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-503 Terazosin Hydrochloride 5 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 71610-478 Terazosin Hydrochloride 1 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC